Richard Buchta
Directeur/Bestuurslid bij BERONI GROUP LIMITED
Actieve functies van Richard Buchta
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BERONI GROUP LIMITED | Directeur/Bestuurslid | 01-07-2020 | - |
Independent Dir/Board Member | 01-07-2020 | - | |
Formulytica Pty Ltd.
Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Directeur/Bestuurslid | - | - |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Directeur/Bestuurslid | 05-05-2021 | - |
Loopbaan van Richard Buchta
Eerdere bekende functies van Richard Buchta
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-12-2014 | - |
Opleiding van Richard Buchta
Monash University | Undergraduate Degree |
Deakin University | Masters Business Admin |
Weizmann Institute of Science | Doctorate Degree |
University of Trieste | Doctorate Degree |
Statistieken
Internationaal
Australië | 6 |
Verenigde Staten | 2 |
Israël | 2 |
Operationeel
Director/Board Member | 3 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Consumer Services | 5 |
Health Technology | 4 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BERONI GROUP LIMITED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Health Technology |
Formulytica Pty Ltd.
Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Commercial Services |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Health Technology |
- Beurs
- Insiders
- Richard Buchta
- Ervaring